Understanding HPV vaccine preferences among sexual minority men living with HIV in Abuja, Nigeria using a discrete choice experiment

BACKGROUND: Sexual minority men (SMM) in Nigeria face a disproportionate burden of HPV-related diseases, yet HPV vaccination uptake remains limited due to structural, financial, and sociocultural barriers. Understanding SMM's preferences for vaccination delivery is critical to designing accessible, affirming, and equitable prevention strategies. METHODS: A discrete choice experiment (DCE) was conducted with 250 SMM receiving HIV-related care at an affirming clinic in Abuja, Nigeria. Seven attributes were identified through literature review and stakeholder engagement. Participants completed 12 choice tasks comparing hypothetical HPV vaccination scenarios. Hierarchical Bayes estimation was used to derive individual-level utilities and attribute importance scores. RESULTS: Participants strongly preferred receiving HPV-related services in SMM-affirming settings and at no cost. Setting type (19.4%) and cost (19.2%) were the most influential attributes, followed by wart prevention (11.4%) and information availability (7.8%). Services described as protecting others from HPV-related outcomes, prevent warts, and require moderate travel (60 min) were moderately preferred. Higher levels of vaccine protection and information availability were less influential in decision-making. CONCLUSIONS: Preferences among SMM in Nigeria emphasize the need for free, affirming, and inclusive HPV vaccination services. Addressing structural barriers, especially stigma and cost, will be essential to increasing vaccine uptake. Findings support targeted, community-informed strategies to reduce HPV disparities and promote health equity.

Authors

Institutions

Publication Details

Journal
Vaccine
Published
2026-05-30
DOI
https://doi.org/10.1016/j.vaccine.2026.128771
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Understanding HPV vaccine preferences among sexual minority men living with HIV in Abuja, Nigeria using a discrete choice experiment

Abayomi Aka, John Chama, Connor Volpi, Ruxton Adebiyi et al.
Vaccine
Cervical Cancer and HPV Research
article

Understanding HPV vaccine preferences among sexual minority men living with HIV in Abuja, Nigeria using a discrete choice experiment

Abayomi Aka, John Chama, Connor Volpi, Ruxton Adebiyi, Uchenna Ononaku, Jumoke A Aigoro, Yerima Jibrin Bawa, Kazeem E. Kolawole, S. B. Adebajo, Naomi Ayuba, Juan Marcos Gonzalez, Ashley Shutt, Patrick Dakum, Stephen E. Goldstone, Karin E. Tobin, Joel M. Palefsky, Rebecca G. Nowak
article en

Abstract

BACKGROUND: Sexual minority men (SMM) in Nigeria face a disproportionate burden of HPV-related diseases, yet HPV vaccination uptake remains limited due to structural, financial, and sociocultural barriers. Understanding SMM's preferences for vaccination delivery is critical to designing accessible, affirming, and equitable prevention strategies. METHODS: A discrete choice experiment (DCE) was conducted with 250 SMM receiving HIV-related care at an affirming clinic in Abuja, Nigeria. Seven attributes were identified through literature review and stakeholder engagement. Participants completed 12 choice tasks comparing hypothetical HPV vaccination scenarios. Hierarchical Bayes estimation was used to derive individual-level utilities and attribute importance scores. RESULTS: Participants strongly preferred receiving HPV-related services in SMM-affirming settings and at no cost. Setting type (19.4%) and cost (19.2%) were the most influential attributes, followed by wart prevention (11.4%) and information availability (7.8%). Services described as protecting others from HPV-related outcomes, prevent warts, and require moderate travel (60 min) were moderately preferred. Higher levels of vaccine protection and information availability were less influential in decision-making. CONCLUSIONS: Preferences among SMM in Nigeria emphasize the need for free, affirming, and inclusive HPV vaccination services. Addressing structural barriers, especially stigma and cost, will be essential to increasing vaccine uptake. Findings support targeted, community-informed strategies to reduce HPV disparities and promote health equity.

VaccineVol. 87
University of Maryland, Baltimore (US), Johns Hopkins University (US), Duke University (US), University of California, San Francisco (US), Institute of Human Virology (NG), Nigeria Centre for Disease Control (NG), Icahn School of Medicine at Mount Sinai (US)
National Institutes of Health
Gender equality
Openalex Percentile: Top 6%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.